Cargando…

FAAH inhibition ameliorates breast cancer in a murine model

Breast cancer is the leading cancer among females worldwide. Disease outcome depends on the hormonal status of the cancer and whether or not it is metastatic, but there is a need for more efficacious therapeutic strategies where first line treatment fails. In this study, Fatty Acid Amide Hydrolase (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tripathy, Mallika, Bui, Amy, Henderson, Jared, Sun, Jeffrey, Woods, Christian Rutan, Somani, Soumya, Doan, Thao, Louis Sam Titus, Anto Sam Crosslee, Mohan, Chandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624203/ https://www.ncbi.nlm.nih.gov/pubmed/37921652 http://dx.doi.org/10.18632/oncotarget.28534

Ejemplares similares

Baseline Elevations of Leukotriene Metabolites and Altered Plasmalogens Are Prognostic Biomarkers of Plaque Progression in Systemic Lupus Erythematosus
por: Baig, Sahar, et al.
Publicado: (2022)

Resistin, Elastase, and Lactoferrin as Potential Plasma Biomarkers of Pediatric Inflammatory Bowel Disease Based on Comprehensive Proteomic Screens
por: Louis Sam Titus, Anto Sam Crosslee, et al.
Publicado: (2022)

Urine protein biomarkers of bladder cancer arising from 16-plex antibody-based screens
por: Vanarsa, Kamala, et al.
Publicado: (2021)

Neuroprotection by Heat Shock Factor-1 (HSF1) and Trimerization-Deficient Mutant Identifies Novel Alterations in Gene Expression
por: Qu, Zhe, et al.
Publicado: (2018)

The Bdnf and Npas4 genes are targets of HDAC3-mediated transcriptional repression
por: Louis Sam Titus, Anto Sam Crosslee, et al.
Publicado: (2019)

FAAH inhibitors in the limelight, but regrettably
por: Mallet, Christophe, et al.
Publicado: (2016)

FAAH selectively influences placebo effects
por: Peciña, M., et al.
Publicado: (2013)

The endocannabinoid hydrolase FAAH is an allosteric enzyme
por: Dainese, Enrico, et al.
Publicado: (2020)

A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional–motivational reactivity
por: Conzelmann, Annette, et al.
Publicado: (2012)

Activity‐based Photoacoustic Probes Reveal Elevated Intestinal MGL and FAAH Activity in a Murine Model of Obesity
por: Lucero, Melissa Y., et al.
Publicado: (2022)

Role of FAAH-Like Anandamide Transporter in Anandamide Inactivation
por: Leung, KwanNok, et al.
Publicado: (2013)

Author Correction: The endocannabinoid hydrolase FAAH is an allosteric enzyme
por: Dainese, Enrico, et al.
Publicado: (2020)

Potentiation of amyloid beta phagocytosis and amelioration of synaptic dysfunction upon FAAH deletion in a mouse model of Alzheimer's disease
por: Ruiz-Pérez, Gonzalo, et al.
Publicado: (2021)

The endocannabinoid gene faah2a modulates stress-associated behavior in zebrafish
por: Krug, Randall G., et al.
Publicado: (2018)

Molecular Basis for Non-Covalent, Non-Competitive FAAH Inhibition
por: Morgillo, Carmine Marco, et al.
Publicado: (2022)

Molecular basis of FAAH-OUT-associated human pain insensitivity
por: Mikaeili, Hajar, et al.
Publicado: (2023)

Endocannabinoid Regulation of Acute and Protracted Nicotine Withdrawal: Effect of FAAH Inhibition
por: Cippitelli, Andrea, et al.
Publicado: (2011)

Potential Therapeutic Value of a Novel FAAH Inhibitor for the Treatment of Anxiety
por: Marco, Eva M., et al.
Publicado: (2015)

FAAH genetic variation enhances fronto-amygdala function in mouse and human
por: Dincheva, Iva, et al.
Publicado: (2015)

A Swath Label-Free Proteomics insight into the Faah(−/−) Mouse Liver
por: Hamid, Zeeshan, et al.
Publicado: (2018)

Analgesic effects of FAAH inhibitor in the insular cortex of nerve-injured rats
por: Jee Kim, Min, et al.
Publicado: (2018)

A catalytically silent FAAH-1 variant drives anandamide transport in neurons
por: Fu, Jin, et al.
Publicado: (2011)

Metabolism and disposition of MM-433593, a selective FAAH-1 inhibitor, in monkeys
por: Banijamali, Ali R, et al.
Publicado: (2014)

Beyond the Canonical Endocannabinoid System. A Screening of PPAR Ligands as FAAH Inhibitors
por: Brunetti, Leonardo, et al.
Publicado: (2020)

FAAH and CNR1 Polymorphisms in the Endocannabinoid System and Alcohol-Related Sleep Quality
por: Soundararajan, Soundarya, et al.
Publicado: (2021)

FAAH rs324420 Polymorphism Is Associated with Performance in Elite Rink-Hockey Players
por: Silva, Hugo-Henrique, et al.
Publicado: (2022)

Activity of FAAH-Inhibitor JZP327A in an Experimental Rat Model of Migraine
por: Greco, Rosaria, et al.
Publicado: (2023)

Peripheral Effects of FAAH Deficiency on Fuel and Energy Homeostasis: Role of Dysregulated Lysine Acetylation
por: Vaitheesvaran, Bhavapriya, et al.
Publicado: (2012)

Ketoconazole Inhibits the Cellular Uptake of Anandamide via Inhibition of FAAH at Pharmacologically Relevant Concentrations
por: Björklund, Emmelie, et al.
Publicado: (2014)

The Molecular Basis for Dual Fatty Acid Amide Hydrolase (FAAH)/Cyclooxygenase (COX) Inhibition
por: Palermo, Giulia, et al.
Publicado: (2015)

The FAAH Inhibitor URB597 Modulates Lipid Mediators in the Brain of Rats with Spontaneous Hypertension
por: Biernacki, Michał, et al.
Publicado: (2020)

Nitric oxide positively affects endometrial receptivity via FAAH and NAPE-PLD in vitro
por: Melford, Sarah E, et al.
Publicado: (2021)

Hexafluoroisopropyl Carbamates as Selective MAGL and Dual MAGL/FAAH Inhibitors: Biochemical and Physicochemical Properties
por: Barth, Maximilian, et al.
Publicado: (2022)

Novel Associations between FAAH Genetic Variants and Postoperative Central Opioid related Adverse Effects
por: Sadhasivam, Senthilkumar, et al.
Publicado: (2015)

Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors
por: Bedse, Gaurav, et al.
Publicado: (2018)

Expression and localization of CB1R, NAPE-PLD, and FAAH in the vervet monkey nucleus accumbens
por: Kucera, Ryan, et al.
Publicado: (2018)

Microdeletion in a FAAH pseudogene identified in a patient with high anandamide concentrations and pain insensitivity
por: Habib, Abdella M., et al.
Publicado: (2019)

Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors
por: Ren, Si-yu, et al.
Publicado: (2020)

Cooperative enzymatic control of N-acyl amino acids by PM20D1 and FAAH
por: Kim, Joon T, et al.
Publicado: (2020)

Fatty Acid Amide Hydrolase (FAAH) Inhibition Modulates Amyloid-Beta-Induced Microglia Polarization
por: Grieco, Maddalena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0gock235afif7ibanua716t85s